Good morning to all. I have been invested in CY
Post# of 153886
(Total Views: 653)
Posted On: 04/06/2020 8:21:53 AM
Good morning to all.
I have been invested in CYDY for many years now. For what some of you might think is déjà vu, todays news is not. My perspective is different as I have been following the narrative of CYDY first with HIV, then with Oncology then with COVID.
These news are important (for me), and this is why:
This means a lot !!. First, Leronlimab usage is being EXTENDED, as per previous post, this is what I predicted will happen if the therapeutic benefits were evident. Why would other hospitals and doctors start treating more patients with Leronlimab ?. Simple: because the medical community (first doctors) have indicated to them that it is working !!! (doctors are smart and responsible, they will not use anything that they think will not help their patients).
This is all I need to know. Is working.
This (for me, maybe no for some of you) is very important. Some statistical analysis could be run on the probability of two out of 15, however, this is a fool's errand, at this time, as probably more are coming and we don't know what would happen if they had not been treated.
We probably saved some lives. This is all I need to know.
Management is working hard, and moving fast. We have initiated the mild-to-moderate trial. Also, the 2b/3 severe trial is initiating this week. If some of you think this is a boring-details communication and there is no "meat" on it, let me give you an advice: wake up. Some of us have been waiting for years for half the news that we get now almost daily.
Please don't get spoiled and keep the due proportion of things, if not for intelectual honestly sake, but for your investment's sake.
These news is great, rich and promising, event if the rest of the world doesn't think so.
And that is all I need to know.
I have been invested in CYDY for many years now. For what some of you might think is déjà vu, todays news is not. My perspective is different as I have been following the narrative of CYDY first with HIV, then with Oncology then with COVID.
These news are important (for me), and this is why:
Quote:
10 patients treated at a leading medical center in the New York City area and five patients at three other hospitals, all under an emergency investigational new drug (EIND), which were granted by the U.S. Food and Drug Administration (FDA) for each individual patient.
This means a lot !!. First, Leronlimab usage is being EXTENDED, as per previous post, this is what I predicted will happen if the therapeutic benefits were evident. Why would other hospitals and doctors start treating more patients with Leronlimab ?. Simple: because the medical community (first doctors) have indicated to them that it is working !!! (doctors are smart and responsible, they will not use anything that they think will not help their patients).
This is all I need to know. Is working.
Quote:
Two Patients Have Already Extubated
This (for me, maybe no for some of you) is very important. Some statistical analysis could be run on the probability of two out of 15, however, this is a fool's errand, at this time, as probably more are coming and we don't know what would happen if they had not been treated.
We probably saved some lives. This is all I need to know.
Quote:
the first two COVID-19 patients have been treated with leronlimab under the Company’s Phase 2 randomized clinical trial, which is for patients with mild-to-moderate indications.
Management is working hard, and moving fast. We have initiated the mild-to-moderate trial. Also, the 2b/3 severe trial is initiating this week. If some of you think this is a boring-details communication and there is no "meat" on it, let me give you an advice: wake up. Some of us have been waiting for years for half the news that we get now almost daily.
Please don't get spoiled and keep the due proportion of things, if not for intelectual honestly sake, but for your investment's sake.
These news is great, rich and promising, event if the rest of the world doesn't think so.
And that is all I need to know.
(22)
(0)